ArticleLeukemia2015

β-Catenin is required for intrinsic but not extrinsic BCR-ABL1 kinase-independent resistance to tyrosine kinase inhibitors in chronic myeloid leukemia.

A M Eiring et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.